Lifecore Biomedical, Inc. (FRA:LDE)

Market Cap	255.26M
Revenue (ttm)	113.70M
Net Income (ttm)	-39.14M
Shares Out	n/a
EPS (ttm)	-1.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	189
Open	6.65
Previous Close	6.65
Day's Range	6.65 - 6.65
52-Week Range	4.56 - 7.45
Beta	n/a
RSI	58.33
Earnings Date	Jan 2, 2026

About Lifecore Biomedical

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. Its product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot stu...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 406
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LDE

Financial Performance

Financial numbers in USD